Intech Investment Management LLC Reduces Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Intech Investment Management LLC lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 31.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 32,905 shares of the company's stock after selling 15,396 shares during the period. Intech Investment Management LLC's holdings in Henry Schein were worth $2,399,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Cromwell Holdings LLC boosted its position in Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after buying an additional 170 shares during the period. Summit Securities Group LLC purchased a new stake in Henry Schein during the 2nd quarter valued at $31,000. Beach Investment Counsel Inc. PA purchased a new stake in Henry Schein during the 2nd quarter valued at $37,000. Blue Trust Inc. lifted its position in shares of Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company's stock worth $60,000 after purchasing an additional 475 shares during the period. Finally, Farther Finance Advisors LLC lifted its position in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock worth $68,000 after purchasing an additional 346 shares during the period. Institutional investors own 96.62% of the company's stock.

Henry Schein Stock Up 2.3 %

NASDAQ:HSIC traded up $1.76 on Monday, reaching $76.84. 2,611,430 shares of the stock traded hands, compared to its average volume of 1,399,551. The company has a market capitalization of $9.58 billion, a price-to-earnings ratio of 31.62, a PEG ratio of 2.15 and a beta of 0.87. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The company's fifty day simple moving average is $70.89 and its 200 day simple moving average is $69.73.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein's revenue was up .4% compared to the same quarter last year. During the same period last year, the business earned $1.32 EPS. Equities analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Analyst Ratings Changes

HSIC has been the subject of several research analyst reports. JPMorgan Chase & Co. dropped their target price on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a research report on Monday, August 12th. UBS Group dropped their target price on shares of Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a research report on Wednesday, August 7th. Robert W. Baird dropped their target price on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a research report on Wednesday, August 7th. StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Finally, Evercore ISI lifted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research report on Tuesday, October 8th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Henry Schein presently has an average rating of "Moderate Buy" and an average price target of $78.89.

Insider Transactions at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. The trade was a 22.65 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company's stock, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.